Search Results for: covid-19
Articles
Vaxart Announces Additional Preclinical COVID-19 Oral Vaccine Data & Publication January 28, 2021
Vaxart, Inc. recently announced additional results from its SARS-CoV-2 Hamster Challenge Study, as well as a peer-reviewed publication in Nature...Ajinomoto Bio-Pharma Services & Humanigen Expand Manufacturing Agreement to Support Fill Finish for Investigational COVID-19 Therapeutic January 28, 2021
Ajinomoto Bio-Pharma Services and Humanigen, Inc. recently announced the companies will be expanding their manufacturing agreement for the fill finish...Gritstone Advances Second-Generation COVID-19 Vaccine January 21, 2021
Gritstone Oncology, Inc. recently announced it is advancing development of a second-generation vaccine against SARS-CoV-2, the virus that causes COVID-19,...Baxter Biopharma Solutions Announces Sterile Manufacturing Agreement for Novavax’s Covid-19 Vaccine January 14, 2021
Baxter International Inc. recently announced that Baxter BioPharma Solutions has entered into an agreement to provide sterile manufacturing services for NVX-CoV2373, Novavax’s COVID-19 recombinant nanoparticle….
AMRI Included in BARDA CDMO Network in Support of COVID-19 Pandemic Response in the US January 14, 2021
Albany Molecular Research, Inc. recently announced its Albuquerque, NM, facility has been approved for inclusion in the Biomedical Advanced Research...DalCor Announces Launch of Dalcetrapib Clinical Trial for COVID-19 January 14, 2021
DalCor Pharmaceuticals recently announced the initiation of dal-COVID, a Phase 2 proof-of-concept study for dalcetrapib as a potential oral anti-viral...EMA Recommends COVID-19 Vaccine Moderna for Authorization in the EU January 7, 2021
The EMA has recently recommended granting a conditional marketing authorization for COVID-19 Vaccine Moderna to prevent coronavirus disease 2019 (COVID-19)...University of Calgary Joins the Phase 2 Trial of LSALT Peptide for the Treatment of Complications in Hospitalized COVID-19 Patients January 5, 2021
Arch Biopartners Inc. RECENTLY announced the University of Calgary Cumming School of Medicine has joined the Phase 2 trial of its lead drug LSALT peptide (Metablok), targeting the prevention….
Akston Biosciences & LakePharma Announce Strategic Partnership to Manufacture Second-Generation COVID-19 Vaccine January 5, 2021
Akston Biosciences and LakePharma recently announced they have established a strategic partnership in which LakePharma will manufacture commercial quantities of Akston’s...Recipharm Announces Signature of Letter of Intent for Aseptic Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate November 24, 2020
Recipharm, a leading contract development and manufacturing organization (CDMO), recently announced that it has signed a letter of intent with Moderna, a US-based biotech company, to formulate, fill, and….
AB201 Development as a Potential Treatment for COVID-19 Receives US FDA Fast-Track Designation November 24, 2020
ARCA biopharma, Inc. recently announced the US FDA has designated as a Fast-Track development program the investigation of AB201 as...VACCINE DEVELOPMENT - COVID-19 Vaccine Focusing on T Cells to Protect the Most Vulnerable November 23, 2020
Jeffrey Wolf, MBA, JD, says while most vaccines in development are targeted to protect healthy people, few are focusing on those who are most at risk – seniors and those with co-morbidities like heart failure, obesity, or type 2 diabetes.
EXECUTIVE INTERVIEW - Yourway: Supporting COVID-19 Studies & Vaccine Distribution November 23, 2020
Leandro Moreira, Senior Vice President, Marketing and Business Development, Yourway, discusses what role the company will play in globally transporting COVID-19 vaccine(s), how Yourway is gearing up for this project, and the challenges of this extraordinary task.
Samsung Biologics Announces Strategic Manufacturing Partnership With Lilly to Accelerate Delivery of COVID-19 Antibody Treatments November 18, 2020
Samsung Biologics’ partnership with Eli Lilly and Company is expected to greatly accelerate the global supply for Lilly’s COVID-19 antibody therapies through a long-term manufacturing agreement….
BioAegis Therapeutics Expands Phase 2 COVID-19 Treatment Clinical Trial November 18, 2020
BioAegis Therapeutics Inc. recently announced it has expanded its clinical trial in severe COVID-19 to additional sites in Europe. The...Atossa Therapeutics Announces Preliminary Results from Phase 1 Clinical Study of Nasal Spray Being Developed for COVID-19 November 11, 2020
Atossa Therapeutics, Inc. recently announced blinded preliminary results from its Phase 1 clinical study using Atossa’s proprietary drug candidate AT-301...Halberd Corporation Files for Patent Protection on Enhanced Nasal Spray to Prevent Covid-19 November 11, 2020
Halberd Corporation reported the filing of a Covid-19 provisional patent on an enhanced nasal spray. The application, Nasal Spray to...Croda Enters Contract With Pfizer for Innovative Delivery System for COVID-19 Vaccine November 11, 2020
Croda International Plc recently announced it has entered into an agreement with Pfizer Inc. to supply novel excipients used in the manufacture of a COVID-19….
Altimmune Adds Lonza as a Manufacturing Partner for Supply of AdCOVID its Single-Dose Intranasal Vaccine Candidate for COVID-19 November 11, 2020
Altimmune, Inc. recently announced that it entered into an agreement with Lonza for the manufacturing of AdCOVID, Altimmune’s next-generation, single-dose...Mateon Therapeutics & Windlas Biotech Enter Commercialization Agreement for Covid-19 Drug November 11, 2020
Mateon Therapeutics recently announced an agreement with Windlas Biotech Pvt. Ltd. of India (Windlas) to commercialize ARTIVeda, Mateon’s lead ethnobiology….
